Neuroscience Marketplace
future marketplace

Epilepsy: newer agents with greater efficacy especially toward seizure freedom, this will open the market for greater brand agent usage.

The technology for Neurostimulation will be greatly enhanced, new and improved techniques will be introduced.

The current adult market is dominated by generic products, many of which are 30 years since introduction with side effects and marginal seizure freedom rates.

In fact, 95% of all anti-seizure medication prescriptions written for a generic. 

In addition, 25% of all Level four epilepsy centers are actually Surgery or neurostimulation accounts, their usage of brand drugs is very minimal.

The reason is because the procedures are a form of economic value for the center and clinicians involved. 

To introduce a product into the market will require significant seizure freedom rates, simple dosing and a very aggressive market access campaign.

We would like the opportunity to provide quality answers and a strategy for you, please contact us.